Skip to content

Clinical trials

Phase 2 Cystic Fibrosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cystic Fibrosis Phase: Phase 2 Country / region: Germany Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20085
20094
20101
20111
20122
20142
20153
20163
20173
20181
20194
20221
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated8
Boehringer Ingelheim3
Lakefront Biotherapeutics NV3
AlgiPharma AS2
Bayer2
Corbus Pharmaceuticals Inc.2
Gilead Sciences2
Heidelberg University2
University of Jena2
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cystic Fibrosis36
Pseudomonas Infections4
Genetic Diseases, Inborn2
Infant, Newborn, Diseases2
Lung Diseases2
Pancreatic Diseases2
Bronchiectasis1
Burkholderia Infections1
Digestive System Diseases1
Fibrosis1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.